Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
99.18%
-
Total 13F principal
-
$402,317,675
-
Principal change
-
+$11,865,000
-
Total reported market value
-
$398,332,341
-
Number of holders
-
39
-
Value change
-
+$12,044,634
-
Number of buys
-
12
-
Number of sells
-
15
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q4 2021
As of 31 Dec 2021,
SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$402,317,675
in principal (par value) of the bond.
The largest 10 bondholders included
TENOR CAPITAL MANAGEMENT Co., L.P., Radcliffe Capital Management, L.P., Opti Capital Management, LP, DeepCurrents Investment Group LLC, JPMORGAN CHASE & CO, OAKTREE CAPITAL MANAGEMENT LP, AVIVA PLC, Invesco Ltd., Polar Capital Holdings Plc, and Jefferies Group LLC.
This page lists
39
institutional bondholders reporting positions
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.